Medicis Pharmaceutical (MRX) Competitors

BGC Group (NASDAQ:BGC) and Medicis Pharmaceutical (NYSE:MRX) are both mid-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation, community ranking and profitability.

Does the MarketBeat Community believe in BGC or MRX?

BGC Group received 164 more outperform votes than Medicis Pharmaceutical when rated by MarketBeat users. However, 67.65% of users gave Medicis Pharmaceutical an outperform vote while only 59.96% of users gave BGC Group an outperform vote.

Company	Underperform	Outperform
BGC Group	Outperform Votes 325 59.96%	Underperform Votes 217 40.04%
Medicis Pharmaceutical	Outperform Votes 161 67.65%	Underperform Votes 77 32.35%

Does the media favor BGC or MRX?

In the previous week, BGC Group and BGC Group both had 1 articles in the media. BGC Group's average media sentiment score of 0.56 beat Medicis Pharmaceutical's score of 0.00 indicating that BGC Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BGC Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medicis Pharmaceutical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals believe in BGC or MRX?

52.1% of BGC Group shares are owned by institutional investors. 26.3% of BGC Group shares are owned by insiders. Comparatively, 3.8% of Medicis Pharmaceutical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is BGC or MRX more profitable?

BGC Group has a net margin of 5.59% compared to Medicis Pharmaceutical's net margin of 0.00%. BGC Group's return on equity of 47.55% beat Medicis Pharmaceutical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BGC Group	5.59%	47.55%	11.71%
Medicis Pharmaceutical	N/A	N/A	N/A

Is BGC or MRX a better dividend stock?

BGC Group pays an annual dividend of $0.08 per share and has a dividend yield of 0.9%. Medicis Pharmaceutical pays an annual dividend of $0.56 per share and has a dividend yield of 1.3%. BGC Group pays out 30.8% of its earnings in the form of a dividend.

Do analysts recommend BGC or MRX?

BGC Group presently has a consensus price target of $14.50, indicating a potential upside of 61.38%. Medicis Pharmaceutical has a consensus price target of $35.63, indicating a potential downside of 15.73%. Given BGC Group's stronger consensus rating and higher possible upside, equities analysts clearly believe BGC Group is more favorable than Medicis Pharmaceutical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BGC Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Medicis Pharmaceutical	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Which has higher valuation & earnings, BGC or MRX?

Medicis Pharmaceutical has lower revenue, but higher earnings than BGC Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BGC Group	$2.21B	1.97	$126.99M	$0.26	34.56
Medicis Pharmaceutical	$1.24B	2.39	$141.30M	N/A	N/A

Summary

BGC Group beats Medicis Pharmaceutical on 10 of the 16 factors compared between the two stocks.